Why well-insured patients should demand value-based insurance benefits: Commentary

JAMA

Volumn 297, Issue 22, 2007, Pages 2515-2518

  Denny, Colleen C ^a   Emanuel, Ezekiel J ^a   Pearson, Steven D ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CETUXIMAB; NEUROLEPTIC AGENT;

COLON CANCER; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH SERVICE; HUMAN; INSURANCE; MEDICAL DECISION MAKING; NOTE; PRIORITY JOURNAL; SCHIZOPHRENIA; UNITED STATES; ARTICLE; COST BENEFIT ANALYSIS; ECONOMICS; ETHICS;

COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HEALTH EXPENDITURES; INSURANCE, HEALTH; UNITED STATES;

EID: 34250305626     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.297.22.2515     Document Type: Note

References (24)

1. Pearson SD, Sabin JE, Emanuel EJ. No Margin, No Mission: Health Care Organizations and the Quest for Ethical Excellence. New York, NY: Oxford University Press; 2003.
2. Washington Post-ABC News Poll: Health Care. Washington, DC: The Washington Post Co; October 20, 2003.
3. Ubel PA. Pricing Life: Why It's Time for Health Care Rationing. Cambridge, Mass: Bradford Books; 2000.
4. Fendrick AM, Chernew ME. Value-based insurance design: a "clinically sensitive" approach to preserve quality and contain costs. Am J Manag Care. 2006;12:18-20.
5. Poisal JA, Truffer C, Smith S, et al. Health spending projections through 2016: modest changes obscure part D's impact. Health Aff (Millwood). 2007;26:w242-w253.
6. Aaron H. A healthcare prescription that's hard to swallow. Los Angeles Times. January 30, 2006.
7. Bodenheimer T. High and rising health care costs, part 2: technologic innovation. Ann Intern Med. 2005;142:932-937.
8. Pauly MV. Competition andnewtechnology. Health Aff (Millwood). 2005;24:1523-1535.
9. Polsky D, Doshi JA, Bauer MS, Glick HA. Clinical trial-based cost-effectiveness analyses of antipsychotic use. Am J Psychiatry. 2006;163:2047-2056.
10. Schrag D. The price tag on progress - chemotherapy for colorectal cancer. N Engl J Med. 2004;351:317-319.
11. Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med. 2004;351:337-345.
12. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335-2342.
13. Sacramento Health Decisions. Cost-Effectiveness as a Criterion for Medical and Coverage Decisions. Saramento, Calif: Sacramento Health Decisions; 2001.
14. Kaiser Family Foundation and Health Research and Educational Trust. Employee Health Benefits: 2005 Annual Survey. Menlo Park, Calif: Henry J. Kaiser Family Foundation; 2005.
15. Blumenthal D. Employer-sponsored insurance - riding the health care tiger. N Engl J Med. 2006;355:195-202.
16. Kaiser Family Foundation and Health Research and Educational Trust. Employer Health Benefits: 2005 Annual Survey. Menlo Park, Calif: Henry J. Kaiser Family Foundation; 2005.
17. Zappone C. Healthcare, energy drive up college costs. August 9, 2006. http://money.cnn.com/2006/08/08/pf/college/cost_college/index.htm?postversion= 2006080909. Accessed April 24, 2007.
18. Selingo J. The disappearing state in public higher education. Chron High Educ. 2003;49:A22.
19. Vu P. Tuition hikes smaller than in past years. August 21, 2006. http://www.stateline.org/live/details/story?contentId=135512. Accessibility verified May 2, 2007.
20. DeNavas-Walt C, Proctor BD, Lee CH. Income, Poverty, and Health Insurance Coverage in the United States: 2005. Washington, DC: US Census Bureau; 2006.
21. Pearson SD, Rawlins MD. Quality, innovation, and value for money: NICE and the British National Health Service. JAMA. 2005;294:2618-2622.
22. Fendrick AM, Smith DG, Chernew ME, Shah SN. A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost. Am J Manag Care. 2001;7:861-867.
23. Deyo RA, Nachemson A, Mirza SK. Spinal-fusion surgery - the case for restraint. Spine J. 2004;4:S138-S142.
24. Krohmal BJ, Emanuel EJ. Access and ability to pay: the ethics of a tiered health care system. Arch Intern Med. 2007;167:433-437.